Why is Nidan Laborator. falling/rising?

As of 04-Nov, Nidan Laboratories & Healthcare Ltd is experiencing a price increase, with its current price at 19.85, reflecting a rise of 0.7 or 3.66%. Today's performance indicates that the stock has outperformed its sector by 4.01%, and it is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. The stock has shown a positive trend in investor participation, with a delivery volume increase of 52.17% compared to the 5-day average. However, despite the recent uptick, the stock has faced significant challenges over the past year, generating a return of -33.72% and a profit decline of -40%. The company has not declared results in the last six months, indicating weak long-term fundamental strength, and its ability to service debt is concerning due to a poor EBIT to Interest ratio.
In the broader market context, Nidan Laboratories has outperformed the Sensex in the short term, with a 1-week return of +1.79% compared to the benchmark's -1.31%. However, the stock's long-term performance remains troubling, with a significant underperformance against the benchmark over the last three years, including a -62.90% return over that period. While the stock's recent price movement may suggest a temporary recovery, the underlying financial weaknesses and consistent underperformance against broader market indices highlight ongoing risks for investors.